Alexandre Berda

Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA.

Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA.

European Satellite Operators Association engages in the provision of information communication services. It includes aviation. broadband, broadcasting, development, emergency communications, maritime, oil and gas, agriculture and fisheries, and mobile backhaul. It also offers artificial satellite such as operating in space; launching satellites; satellite orbits; green satellites; and latency communication networks. The company is headquartered in Brussels, Belgium.

The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members.

Eutelsat SA is engaged in the provision of satellite communications. The company was founded on April 15, 1999 and is headquartered in Paris. France.

Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Hispasat SA engages in the provision of satellite communications services. Its service portfolio includes Spanish and Portuguese content through television, and radio channels through its satellite fleet. The company was founded on June 30, 1989 and is headquartered in Madrid, Spain.

Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain.

SGD SA designs and manufactures glass bottles for the cosmetic and pharmaceutical industries. It offers glass bottles and jars in primary packaging for perfumes and cosmetics, pharmaceuticals, carafes, and glass blocks and insulators. The company was founded 1896 and is headquartered in Paris, France.

European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium.

C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom.

Solaris Mobile Ltd. provides mobile satellite services. It offers terrestrial wireless network infrastructure, manages and provides access to mobile communication networks. The company is headquartered in Dublin, Ireland.

GE Energy Power Conversion GmbH provides engineering, design, manufacturing, supply, commissioning and service of integrated electrical solutions including drive systems, control and automation systems. It focuses on offering drive systems, control, and automation systems. The company was founded in 1999 and is headquartered in Berlin, Germany.

Bioxodes SA develops pharmaceutical products. Its programme Ir-CPI, is the first in a novel class of antithrombotics, and is developed for the prevention of thrombosis in a range of applications including cardiopulmonary bypass grafting and percutaneous coronary intervention. The company was founded by Edmond Godfroid and Michel Guyaux on April 20, 2010 and is headquartered in Marche-en-Famenne, Belgium.

Quethera Ltd. develops treatment for eye diseases. It focuses on developing therapies to reduce progressive visual loss in glaucoma and other conditions affecting the optic nerve. The company was founded by Peter Stuart Widdowson and Keith Robert Graham Martin in 2013 and is headquartered in Cambridge, the United Kingdom.

Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium.

EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium.

Ikarovec Ltd. provides human health care services. The company is headquartered in Canterbury, the United Kingdom.

Skylogic SpA provides broadband satellite communication services for businesses and public administration. The company is headquartered in Turin, Italy.

Part of Eutelsat Communications SA, Eutelsat, Inc. is a leading satellite operator. The company is based in Washington. The American company's satellite fleet serves broadcasters, telecom operators, ISPs, and government agencies, providing access to millions of homes across various continents. Eutelsat is trusted by leading broadcasters to expand their reach and access new markets. With a powerful fleet of satellites, Eutelsat is launching five new satellites in the next three years.